<DOC>
	<DOCNO>NCT01943968</DOCNO>
	<brief_summary>The aim study find biomarker fibrosis vasculopathy systemic sclerosis . We evaluate possible correlation semaphorin 7a , semaphorin 3a lysyl oxidase fibrosis ( lung skin ) vasculopathy patient systemic sclerosis . The result obtain may help u diagnose complication systemic sclerosis hopefully even monitor patient treatment .</brief_summary>
	<brief_title>Lysyl Oxidase , Semaphorin 7a Semaphorin 3a Patients With Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Systemic Sclerosis Patients Written consent participation study Serious active medical condition Other autoimmune rheumatic disease Current past allergic/inflammatory reaction Liver disease Pregnant breastfeed Illegal drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>